The New Jersey Psychiatric Association supports the use of telemedicine in psychiatry, which can safely provide access to care when properly used and certain standards are observed. The use of telemedicine in psychiatry shall meet all applicable federal and state regulations for the practice of medicine, including licensing of providers for the appropriate scope of […]Read More »
In light of the legalization of recreational marijuana for NJ citizens age 21 and above, NJPA is focused on the need to protect adolescents and young adults to age 25 years (AYA) from the harmful effects of cannabis, particularly related to the high percentage and high dose of delta-9-tetrahydrocannabinol (THC) on the developing brain. NJPA […]Read More »
The Prior Authorization process requires physicians to obtain approval from pharmacy benefits plans before payment for medication is approved. This process delays patients’ ability to obtain necessary medication and/or treatment. It also presents time-consuming administrative burdens on physicians, which can lead to a decreased number of patients the physician can treat. Non-physicians are usually hired […]Read More »
According to the CDC, approximately 20% of children and youth suffer from a mental health disorder. Only about 1/3 of those children and youth will receive an appropriate diagnosis and effective treatment. Minority children are even less likely to receive mental health services. Untreated mental health disorders result in a number of serious issues, including […]Read More »
Issue:In our current healthcare system, the treatment of medical illness and behavioral health conditions, including mental health and substance use disorders, are treated as discrete problems as though they were not occurring in the same person. While mental illness should be treated in conjunction with other medical conditions, it is left undetected and untreated most […]Read More »
As the recognition of mental illness becomes more prevalent, the need for treatment resources at all levels of care becomes increasingly more vital. These resources include, but are not limited to, longterm care facilities, short-term care facilities, acute care units, emergency rooms, outpatient psychiatric treatment programs, substance abuse treatment programs, etc. All levels are care, in most […]Read More »
In the context of highly publicized episodes of mass violence in this country, the question often arises as to the role of mental illness as a factor impelling the perpetrators of violence. Therefore, it is important to clarify this matter for the general public and those who establish public policy. The vast majority of violence […]Read More »
Marijuana legalization has been promoted as a public health measure to decrease drug-related crime, as a solution to the harms caused by marijuana criminalization, including incarceration, and as a significant source of tax revenue. These claims have not been validated and must be weighed against the potential negative consequences. Legalization of cannabis will reduce the […]Read More »
In New Jersey, along with our nation as a whole, we are facing a true epidemic of opioid overuse and addiction, which may lead to death by overdose, either deliberate or accidental. Overdose deaths involving prescription or illicit opioids have increased by 200% since the year 2000, which is correlated with a similar increase in […]Read More »
Healthcare insurance companies, through Pharmacy Benefit Management (PBM) policies, typically employ drug formularies which designate which drugs they will pay for, under what circumstances and in what quantities, with or without co-pays. Physicians, particularly those experienced in the medical specialty under which drugs are typically prescribed, may not be present on formulary review boards which […]Read More »
The New Jersey Psychiatric Association supports the use of telemedicine in psychiatry, which can safely...
In light of the legalization of recreational marijuana for NJ citizens age 21 and above,...
The Prior Authorization process requires physicians to obtain approval from pharmacy benefits plans before payment...
While the New Jersey Psychiatric Association (NJPA) makes every effort to post accurate and reliable information, it does not guarantee that the information on this website is complete, accurate or up to date, nor does it assume responsibility for the use or application of any posted material. The NJPA takes no responsibility for any error, omission or other discrepancy between the electronic and any printed versions of documents. This website is intended solely for the purpose of electronically providing members, non-member psychiatrists and the public with information and convenient access to a variety of resources. The NJPA cannot provide specific advice or counsel, whether medical, legal or otherwise. This website links to websites maintained by other entities. Although efforts have been taken to assure that these linked websites are maintained by reputable organizations, the NJPA is not responsible for the information and opinions expressed in those linked sites.